ENTRY       D09588                      Drug
NAME        Briakinumab (USAN/INN)
FORMULA     C6376H9874N1722O1992S44
EXACT_MASS  143845.1988
MOL_WEIGHT  143933.825
SEQUENCE    (Heavy chain)
            QVQLVESGGG VVQPGRSLRL SCAASGFTFS SYGMHWVRQA PGKGLEWVAF IRYDGSNKYY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCKTHG SHDNWGQGTM VTVSSASTKG
            PSVFPLAPSS KSTSGGTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA VLQSSGLYSL
            SSVVTVPSSS LGTQTYICNV NHKPSNTKVD KKVEPKSCDK THTCPPCPAP ELLGGPSVFL
            FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VKFNWYVDGV EVHNAKTKPR EEQYNSTYRV
            VSVLTVLHQD WLNGKEYKCK VSNKALPAPI EKTISKAKGQ PREPQVYTLP PSREEMTKNQ
            VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSKLTV DKSRWQQGNV
            FSCSVMHEAL HNHYTQKSLS LSPGK
            (Light chain)
            QSVLTQPPSV SGAPGQRVTI SCSGSRSNIG SNTVKWYQQL PGTAPKLLIY YNDQRPSGVP
            DRFSGSKSGT SASLAITGLQ AEDEADYYCQ SYDRYTHPAL LFGTGTKVTV LGQPKAAPSV
            TLFPPSSEEL QANKATLVCL ISDFYPGAVT VAWKADSSPV KAGVETTTPS KQSNNKYAAS
            SYLSLTPEQW KSHRSYSCQV THEGSTVEKT VAPTECS
            (Disulfide bridge: H22-H96, H142-H198, H259-H319, H65-H423, H224-H'224, H227-H'227, L22-L89, L139-L198, H218-L216)
  TYPE      Peptide
CLASS       Immunological agent
             DG02019  Interleukin inhibitor
REMARK      ATC code: L04AC09
EFFICACY    Anti-inflammatory, Immunosuppressant, Anti-IL12/23 antibody
  TYPE      Monoclonal antibody, bispecific antibody
TARGET      IL12 [HSA:3592 3593] [KO:K05406 K05425]
            IL23A [HSA:51561] [KO:K05426]
  PATHWAY   hsa04060(3592+3593+51561)  Cytokine-cytokine receptor interaction
            hsa04630(3592+3593+51561)  JAK-STAT signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AC Interleukin inhibitors
                 L04AC09 Briakinumab
                  D09588  Briakinumab (USAN/INN)
            Drug groups [BR:br08330]
             Immunological agent
              DG02019  Interleukin inhibitor
               D09588  Briakinumab
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL12
                 D09588  Briakinumab (USAN/INN)
                IL23A
                 D09588  Briakinumab (USAN/INN)
DBLINKS     CAS: 339308-60-0
            PubChem: 124490328
///
